FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078114088> ?p ?o ?g. }

• W2078114088 endingPage "491" @default.
• W2078114088 startingPage "486" @default.
• W2078114088 abstract "Survivin, a member of inhibitor of apoptosis family of proteins, plays important roles in both cell proliferation and cell death. We previously observed that Survivin is overexpressed in leukemic cell lines and blasts from patients with acute myelogenous leukemia (AML). To understand the roles of Survivin in AML and search for new approaches to the treatment of AML, we inhibited Survivin expression in HL-60 cells with a Survivin anti-sense oligonucleotide (sur-AS-ODN) (ISIS 23722). This blocked significant numbers of HL-60 cells in G2/M phase, and halted cell proliferation at 24 hrs and progressing over time. There was only a slight increase in the number of apoptotic cells at 24 hrs compared with cells treated with nonsense oligonucleotide (NS-ODN). At 48 hrs, however, there were significant increases in sub-G1 phase and annexin V+ cells, suggesting that cell division defects caused cell death. This was supported by the finding that a reduction in the Survivin protein by sur-AS-ODN in cells under serum-free medium did not induce G2/M block and cell death compared to cells treated with NS-ODN. The formation of polyploid cells was observed 48 hrs after sur-AS-ODN treatment, as was the activation of caspase 3, which suggested that apoptotic cell death had occurred. The mitochondrial release of cytochrome C and Smac and the nuclear translocation of the apoptosis-inducing factor were also detected. Our results suggest that Survivin is essential for cell cycle progression in leukemic cells. Reduced Survivin expression causes a cell-cycle defect that leads to cell death through a mitochondrial pathway. This finding has potential utility for therapy of patients with AML." @default.
• W2078114088 created "2016-06-24" @default.
• W2078114088 creator A5004888325 @default.
• W2078114088 creator A5023848359 @default.
• W2078114088 creator A5034868940 @default.
• W2078114088 creator A5052186917 @default.
• W2078114088 creator A5075486072 @default.
• W2078114088 creator A5079604596 @default.
• W2078114088 date "2003-09-12" @default.
• W2078114088 modified "2023-09-27" @default.
• W2078114088 title "Targeting Survivin Expression Induces Cell Proliferation Defect and SubsequentCell Death Involving Mitochondrial Pathway in Myeloid Leukemic Cells" @default.
• W2078114088 cites W1523461418 @default.
• W2078114088 cites W1530089119 @default.
• W2078114088 cites W1540060031 @default.
• W2078114088 cites W1540983225 @default.
• W2078114088 cites W1595083214 @default.
• W2078114088 cites W1662899239 @default.
• W2078114088 cites W1893157084 @default.
• W2078114088 cites W1904882776 @default.
• W2078114088 cites W1961680179 @default.
• W2078114088 cites W1972304655 @default.
• W2078114088 cites W1975212546 @default.
• W2078114088 cites W1987671662 @default.
• W2078114088 cites W2035523654 @default.
• W2078114088 cites W2042409437 @default.
• W2078114088 cites W2058115449 @default.
• W2078114088 cites W2078791728 @default.
• W2078114088 cites W2091822635 @default.
• W2078114088 cites W2105035331 @default.
• W2078114088 cites W2155808370 @default.
• W2078114088 cites W2162653594 @default.
• W2078114088 cites W2166291746 @default.
• W2078114088 cites W2264796473 @default.
• W2078114088 cites W2329506722 @default.
• W2078114088 cites W2396068685 @default.
• W2078114088 cites W67676209 @default.
• W2078114088 cites W2035982561 @default.
• W2078114088 doi "https://doi.org/10.4161/cc.2.5.500" @default.
• W2078114088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12963850" @default.
• W2078114088 hasPublicationYear "2003" @default.
• W2078114088 type Work @default.
• W2078114088 sameAs 2078114088 @default.
• W2078114088 citedByCount "54" @default.
• W2078114088 countsByYear W20781140882012 @default.
• W2078114088 countsByYear W20781140882013 @default.
• W2078114088 countsByYear W20781140882014 @default.
• W2078114088 countsByYear W20781140882015 @default.
• W2078114088 countsByYear W20781140882017 @default.
• W2078114088 countsByYear W20781140882018 @default.
• W2078114088 countsByYear W20781140882019 @default.
• W2078114088 countsByYear W20781140882020 @default.
• W2078114088 crossrefType "journal-article" @default.
• W2078114088 hasAuthorship W2078114088A5004888325 @default.
• W2078114088 hasAuthorship W2078114088A5023848359 @default.
• W2078114088 hasAuthorship W2078114088A5034868940 @default.
• W2078114088 hasAuthorship W2078114088A5052186917 @default.
• W2078114088 hasAuthorship W2078114088A5075486072 @default.
• W2078114088 hasAuthorship W2078114088A5079604596 @default.
• W2078114088 hasBestOaLocation W20781140881 @default.
• W2078114088 hasConcept C153911025 @default.
• W2078114088 hasConcept C190283241 @default.
• W2078114088 hasConcept C2775975398 @default.
• W2078114088 hasConcept C2778729363 @default.
• W2078114088 hasConcept C29537977 @default.
• W2078114088 hasConcept C31573885 @default.
• W2078114088 hasConcept C502942594 @default.
• W2078114088 hasConcept C55493867 @default.
• W2078114088 hasConcept C56483683 @default.
• W2078114088 hasConcept C62112901 @default.
• W2078114088 hasConcept C86803240 @default.
• W2078114088 hasConcept C98424977 @default.
• W2078114088 hasConceptScore W2078114088C153911025 @default.
• W2078114088 hasConceptScore W2078114088C190283241 @default.
• W2078114088 hasConceptScore W2078114088C2775975398 @default.
• W2078114088 hasConceptScore W2078114088C2778729363 @default.
• W2078114088 hasConceptScore W2078114088C29537977 @default.
• W2078114088 hasConceptScore W2078114088C31573885 @default.
• W2078114088 hasConceptScore W2078114088C502942594 @default.
• W2078114088 hasConceptScore W2078114088C55493867 @default.
• W2078114088 hasConceptScore W2078114088C56483683 @default.
• W2078114088 hasConceptScore W2078114088C62112901 @default.
• W2078114088 hasConceptScore W2078114088C86803240 @default.
• W2078114088 hasConceptScore W2078114088C98424977 @default.
• W2078114088 hasIssue "5" @default.
• W2078114088 hasLocation W20781140881 @default.
• W2078114088 hasLocation W20781140882 @default.
• W2078114088 hasOpenAccess W2078114088 @default.
• W2078114088 hasPrimaryLocation W20781140881 @default.
• W2078114088 hasRelatedWork W2025863855 @default.
• W2078114088 hasRelatedWork W2123870130 @default.
• W2078114088 hasRelatedWork W2151717296 @default.
• W2078114088 hasRelatedWork W2185175380 @default.
• W2078114088 hasRelatedWork W2358890472 @default.
• W2078114088 hasRelatedWork W2367667778 @default.
• W2078114088 hasRelatedWork W2374067319 @default.
• W2078114088 hasRelatedWork W2383691845 @default.
• W2078114088 hasRelatedWork W2394093643 @default.
• W2078114088 hasRelatedWork W2955113018 @default.

• next